Lever
Lifestyle
- Regular monitoring of copper levels
- Avoiding excessive copper exposure
- Managing liver health
Blutwerte · Marker
Kupfer
Copper · Serum Copper · Cu
Elektrolyte
- Einheit:
- μmol/L
- Abbreviation
- Cu
Serum copper measures the amount of copper in the blood, reflecting the body's copper status.
Reference Ranges
Reference
11–22μmol/L
11
22
LowNormalHigh
Reference
Unit · μmol/LReference ranges can vary based on age and sex; fasting is not required.
Overview
Übersicht
Copper (Cu) is an essential trace element that plays a crucial role in various biological processes, including the function of enzymes involved in oxidation-reduction reactions. It is primarily measured in the blood as serum copper to assess copper status in the body. Clinically, serum copper levels are significant in diagnosing and managing conditions such as Wilson's disease, a genetic disorder characterized by copper accumulation in tissues, and Menkes disease, a disorder of copper transport. Elevated serum copper levels have been associated with increased risk of cardiovascular disease, while low levels can indicate copper deficiency or malabsorption syndromes. For athletes and biohackers, maintaining optimal copper levels is vital for enzymatic functions and overall metabolic health. However, excessive copper can be toxic, and its levels can be influenced by factors such as diet, genetic conditions, and liver function. Researchers found that serum copper levels can vary based on age, sex, and health status, and they recommend considering these factors when interpreting test results.
Klinische Bedeutung
Elevated serum copper levels may indicate Wilson's disease or increased cardiovascular risk, while low levels can suggest copper deficiency, malabsorption, or Menkes disease.
Dynamics
Trend Interpretation
Rising Values
Progressively rising values may suggest worsening of Wilson's disease or increased risk of cardiovascular disease. Retest in 4 weeks if outside the optimal range.
Falling Values
Progressively falling values may indicate improving copper overload conditions or onset of deficiency.
Re-test Interval
4 weeks if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- Wilson's disease
- Chronic liver disease
- Copper toxicity
- Inflammation
- Excessive copper supplementation
Cause
Low Levels
- Menkes disease
- Copper deficiency
- Malabsorption syndromes
- Excessive zinc supplementation
- Chronic diarrhea
Protocol
How to Optimize
Lever
Nutrition
- Consuming copper-rich foods like shellfish and nuts
- Balancing zinc intake
- Ensuring adequate dietary copper
Lever
Supplementation
- Copper supplements if deficient
- Zinc to manage Wilson's disease
Note:
Consult a healthcare provider before starting any supplementation, especially if managing conditions like Wilson's disease.
Testing Guidelines
✓Fasting Not Required
✓Not Time-Sensitive
Testing Frequency
Annually for healthy adults, more frequently if managing a related condition
Interfering Factors
- Recent copper supplementation
- Acute inflammation
- Liver dysfunction
Related Peptides & Hormones
Ceruloplasmin
hormone or peptideCorrelated with
Open Research Questions
Current research suggests that reference ranges for serum copper levels and their optimal targets in various populations, particularly in relation to cardiovascular disease risk, remain debated. Researchers have not yet established the impact of confounders such as BMI on copper's prognostic value for cardiovascular mortality. Additionally, clinical questions remain unanswered regarding the role of copper biomarkers in differentiating between various copper transport disorders and their potential therapeutic implications.
26 Research Publications
417
Total Citations
11
Human/RCT
2.3
Avg. Influence
2025
Latest
Sort
Filter
01Top
#01
New tools for Wilson's disease diagnosis: exchangeable copper fraction.
HumanInfluence5.0
80
Researchers found that relative exchangeable copper (REC) and exchangeable copper (CuEXC) are reliable biomarkers for diagnosing Wilson's disease. These tests provide rapid, non-invasive assessments of copper overload, facilitating early diagnosis and treatment without waiting for genetic test results.
02Top
#02
Wilson's disease: A master of disguise.
ReviewInfluence3.0
64
This study discussed the challenges in diagnosing Wilson's disease, emphasizing its diverse symptoms and the importance of laboratory evaluations. Researchers found that early recognition and treatment are critical for improving outcomes, highlighting the need for awareness of its nonspecific neurological manifestations.
03Top
#03
Copper in depressive disorder: A systematic review and meta-analysis of observational studies.
Meta-AnalysisInfluence4.0
64
Researchers found that patients with depressive disorder had higher blood levels of copper compared to controls, suggesting a potential link between copper levels and mental health. The study conducted a meta-analysis of 21 studies, indicating that increased blood copper might be associated with depression, although hair copper levels showed no difference.
04
#04
Interactions of trace elements: clinical significance.
UnknownInfluence1.0
52
Researchers examined the interactions between zinc, copper, and lead, noting that zinc deficiency can lead to copper overload. They proposed using zinc therapy to manage copper levels in Wilson's disease, highlighting the importance of trace element interactions in clinical settings.
05
#05
Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma.
HumanInfluence2.0
49
Researchers found that altered copper metabolism may serve as a new biomarker for hepatocellular carcinoma (HCC) detection. Increased copper accumulation was observed in HCC tissues, and copper-64 chloride showed potential in molecular imaging for HCC metastasis. The study suggests that targeting copper metabolism could enhance imaging and therapy for HCC.
06
#06
ATP7A-related copper transport disorders: A systematic review and definition of the clinical subtypes.
ReviewInfluence1.0
23
This systematic review investigated ATP7A-related copper transport disorders, identifying clinical subtypes and their specific characteristics. Researchers found that low ceruloplasmin levels are a sensitive biomarker for these disorders, and early seizures are indicative of classical Menkes disease.
07
#07
Serum copper and the risk of cardiovascular disease death in Finnish men.
Human
23
This study examined the association between serum copper levels and cardiovascular disease (CVD) mortality in Finnish men. Researchers found that higher serum copper levels were linked to an increased risk of CVD death across various body mass index categories.
08
#08
Biochemical diagnosis of Wilson's disease: an update.
Review
18
This paper reviewed the biochemical diagnosis of Wilson's disease, highlighting the limitations of current tests. Researchers found that while serum ceruloplasmin and urinary copper excretion are commonly used, relative exchangeable copper shows high sensitivity and specificity for diagnosis.
09
#09
Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson Disease.
Human
10
This study evaluated the diagnostic performance of copper biomarkers in Wilson's disease. Researchers found that relative exchangeable copper (REC) significantly differentiates patients with Wilson's disease from other liver conditions, suggesting its potential as a reliable diagnostic tool.
10
#10
Iatrogenic copper deficiency: Risks and cautions with zinc prescribing.
Case ReportInfluence1.0
9
Researchers found that zinc-induced copper deficiency is often overlooked, with 50% of diagnosed cases previously undetected. The study emphasizes the need for better monitoring of serum zinc and copper levels in patients prescribed zinc to prevent this rare but significant condition.
Publication Trend
Research publications about Kupfer over time
10totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer